Abstract | BACKGROUND: Epitope-focused immunogens can elicit antibody against the loop neutralizing determinant (LND), a neutralizing epitope found within the 2β2-2β3 loop of protective antigen (PA), which can protect rabbits from high-dose inhalation challenge with Bacillus anthracis Ames strain. Interestingly, data suggests that this epitope is relatively immunosilent in rabbits and non-human primates immunized with full length PA. METHODS: To determine whether the LND is immunosilent among humans vaccinated with PA, we screened antisera from AVA- or placebo-vaccinees from a clinical trial for antibody reactive with the LND. RESULTS: AVA-vaccinee sera had significant PA-specific antibody compared to placebo-vaccinee sera; however, sera from the two cohorts were indistinguishable with regard to the frequency of individuals with antibody specific for the LND. CONCLUSIONS: AVA-vaccinees have a low frequency of antibody reactive with the LND. As with rabbits and non-human primates, the elicitation of LND-specific antibody in humans appears to require immunization with an epitope-focused vaccine.
|
Authors | Jon Oscherwitz, Conrad P Quinn, Kemp B Cease |
Journal | Vaccine
(Vaccine)
Vol. 33
Issue 20
Pg. 2342-6
(May 11 2015)
ISSN: 1873-2518 [Electronic] Netherlands |
PMID | 25820066
(Publication Type: Clinical Trial, Phase IV, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2015 Elsevier Ltd. All rights reserved. |
Chemical References |
- Anthrax Vaccines
- Antibodies, Bacterial
- Antibodies, Neutralizing
- Antigens, Bacterial
- Bacterial Toxins
- Epitopes
- anthrax toxin
|
Topics |
- Anthrax
(prevention & control)
- Anthrax Vaccines
(administration & dosage, immunology)
- Antibodies, Bacterial
(blood)
- Antibodies, Neutralizing
(blood)
- Antigens, Bacterial
(immunology)
- Bacillus anthracis
(immunology)
- Bacterial Toxins
(immunology)
- Enzyme-Linked Immunosorbent Assay
- Epitopes
(immunology)
- Humans
|